Our website address is: https://hassanshehata.co.uk.
When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection.
An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment.
If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.
If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year.
If you visit our login page, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser.
When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select “Remember Me”, your login will persist for two weeks. If you log out of your account, the login cookies will be removed.
If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.
Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website.
These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website.
If you request a password reset, your IP address will be included in the reset email.
If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue.
For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their username). Website administrators can also see and edit that information.
If you have an account on this site, or have left comments, you can request to receive an exported file of the personal data we hold about you, including any data you have provided to us. You can also request that we erase any personal data we hold about you. This does not include any data we are obliged to keep for administrative, legal, or security purposes.
Visitor comments may be checked through an automated spam detection service.
1. | Severe hyponatremia in obstetrics: Presentations and outcome. Retrospective cohort over 10 years. Elbarbary N, Datta T, Viswanatha R, Johnstone H, Shehata H, Ganapathy R. Int J Gynaecol Obstet. 2025 Mar;168(3):1026-1030. doi: 10.1002/ijgo.15939. Epub 2024 Oct 24. PMID: 39445579 |
2. | Wildridge B, Makanjuola D, Johnson A, Ganapathy R, Mountford L, Bell C, Odogwu J, Shehata H. Int J Gynaecol Obstet. 2024 Sep;166(3):1086-1091. doi: 10.1002/ijgo.15492. Epub 2024 Mar 22. PMID: 38520087 |
3. | Managing couples with recurrent miscarriage: A narrative review and practice recommendations. Ali A, Elfituri A, Doumouchtsis SK, Zini ME, Jan H, Ganapathy R, Divakar H, Hod M, Shehata H. Int J Gynaecol Obstet. 2024 Feb;164(2):499-503. doi: 10.1002/ijgo.14971. Epub 2023 Jul 10. PMID: 37431204 Review. |
4. | Shehata H, Elfituri A, Doumouchtsis SK, Zini ME, Ali A, Jan H, Ganapathy R, Divakar H, Hod M. Int J Gynaecol Obstet. 2023 Apr;161 Suppl 1:3-16. doi: 10.1002/ijgo.14717. PMID: 36958854 No abstract available. |
5. | Shehata H, Ali A, Silva-Edge M, Haroon S, Elfituri A, Viswanatha R, Jan H, Akolekar R. BMJ Open. 2022 Jul 13;12(7):e059519. doi: 10.1136/bmjopen-2021-059519. PMID: 35831047 Free PMC article. |
6. | Sperm DNA fragmentation is a novel biomarker for early pregnancy loss. Haddock L, Gordon S, Lewis SEM, Larsen P, Shehata A, Shehata H. Reprod Biomed Online. 2021 Jan;42(1):175-184. doi: 10.1016/j.rbmo.2020.09.016. Epub 2020 Sep 22. PMID: 33082108 |
7. | Recurrent miscarriage: evidence to accelerate action. Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, Brewin J, Abrahams VM, Maheshwari A, Christiansen OB, Stephenson MD, Goddijn M, Oladapo OT, Wijeyaratne CN, Bick D, Shehata H, Small R, Bennett PR, Regan L, Rai R, Bourne T, Kaur R, Pickering O, Brosens JJ, Devall AJ, Gallos ID, Quenby S. Lancet. 2021 May 1;397(10285):1675-1682. doi: 10.1016/S0140-6736(21)00681-4. Epub 2021 Apr 27. PMID: 33915096 |
8. | Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring. Panagiotopoulou O, Syngelaki A, Georgiopoulos G, Simpson J, Akolekar R, Shehata H, Nicolaides K, Charakida M. Am J Obstet Gynecol. 2020 Aug;223(2):246.e1-246.e10. doi: 10.1016/j.ajog.2020.01.054. Epub 2020 Feb 1. PMID: 32017923 Clinical Trial. |
9. | Mousa A, Løvvik T, Hilkka I, Carlsen SM, Morin-Papunen L, Tertti K, Rönnemaa T, Syngelaki A, Nicolaides K, Shehata H, Burden C, Norman JE, Rowan J, Dodd JM, Hague W, Vanky E, Teede HJ. BMJ Open. 2020 May 21;10(5):e036981. doi: 10.1136/bmjopen-2020-036981. PMID: 32444434 Free PMC article. |
10. | Balani J, Hyer SL, Shehata H, Mohareb F. Obstet Med. 2018 Sep;11(3):121-125. doi: 10.1177/1753495X17754149. Epub 2018 Mar 14. PMID: 30214477 Free PMC article. |
11. | Metformin in Pregnancy: Mechanisms and Clinical Applications. Hyer S, Balani J, Shehata H. Int J Mol Sci. 2018 Jul 4;19(7):1954. doi: 10.3390/ijms19071954. PMID: 29973490 Free PMC article. Review. |
12. | Balani J, Hyer S, Syngelaki A, Akolekar R, Nicolaides KH, Johnson A, Shehata H. Obstet Med. 2017 Dec;10(4):170-173. doi: 10.1177/1753495X17725465. Epub 2017 Oct 16. PMID: 29225676 Free PMC article. |
13. | Managing Recurring Obstetric Cholestasis With Metformin. Elfituri A, Ali A, Shehata H. Obstet Gynecol. 2016 Dec;128(6):1320-1323. doi: 10.1097/AOG.0000000000001748. PMID: 27824743 |
14. | Metformin versus Placebo in Obese Pregnant Women without Diabetes. Balani J, Hyer S, Shehata H. N Engl J Med. 2016 Jun 23;374(25):2502. doi: 10.1056/NEJMc1603067. PMID: 27332917 No abstract available. |
15. | Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H. N Engl J Med. 2016 Feb 4;374(5):434-43. doi: 10.1056/NEJMoa1509819. PMID: 26840133 Clinical Trial. |
16. | The importance of visceral fat mass in obese pregnant women and relation with pregnancy outcomes. Balani J, Hyer S, Johnson A, Shehata H. Obstet Med. 2014 Mar;7(1):22-5. doi: 10.1177/1753495X13495192. Epub 2013 Aug 8. PMID: 27512414 Free PMC article. |
17. | Natural killer cells and their activation status in normal pregnancy. Mosimann B, Wagner M, Shehata H, Poon LC, Ford B, Nicolaides KH, Bansal AS. Int J Reprod Med. 2013;2013:906813. doi: 10.1155/2013/906813. Epub 2013 Mar 27. PMID: 25763390 Free PMC article. |
18. | Gastrointestinal and liver disease in pregnancy. Boregowda G, Shehata HA. Best Pract Res Clin Obstet Gynaecol. 2013 Dec;27(6):835-53. doi: 10.1016/j.bpobgyn.2013.07.006. PMID: 24207084 Review. |
19. | Uric acid: is it time to give up routine testing in management of pre-eclampsia? Talaulikar VS, Shehata H. Obstet Med. 2012 Sep;5(3):119-23. doi: 10.1258/om.2011.110075. Epub 2012 Mar 29. PMID: 27582868 Free PMC article. |
20. | Pregnancy outcomes after metformin treatment for gestational diabetes: a case-control study. Balani J, Hyer S, Johnson A, Shehata H. Obstet Med. 2012 Jun;5(2):78-82. doi: 10.1258/om.2012.110092. Epub 2012 Apr 23. PMID: 27579140 Free PMC article. |
21. | Advances in the understanding and management of haematological disorders associated with pregnancy. Shehata H. Best Pract Res Clin Obstet Gynaecol. 2012 Feb;26(1):1-2. doi: 10.1016/j.bpobgyn.2011.10.011. Epub 2011 Nov 16. PMID: 22094325 No abstract available. |
22. | Egbor M, Johnson A, Harris F, Makanjoula D, Shehata H. Obstet Med. 2011 Jun;4(2):83-5. doi: 10.1258/om.2011.100059. Epub 2011 Jun 9. PMID: 27582861 Free PMC article. |
23. | Early prediction of preeclampsia in high-risk women. Shaker OG, Shehata H. J Womens Health (Larchmt). 2011 Apr;20(4):539-44. doi: 10.1089/jwh.2010.2378. Epub 2011 Mar 17. PMID: 21413896 |
24. | Recurrent miscarriage and autoimmunity. Bansal AS, Bajardeen B, Shehata H, Thum MY. Expert Rev Clin Immunol. 2011 Jan;7(1):37-44. doi: 10.1586/eci.10.84. PMID: 21162648 Review. |
25. | Serum cystatin is not a marker of glomerular filtration rate in pregnancy. Bramham K, Makanjuola D, Hussein W, Cafful D, Shehata H. Obstet Med. 2009 Sep;2(3):121-2. doi: 10.1258/om.2009.090019. Epub 2009 Sep 1. PMID: 27582826 Free PMC article. |
26. | Balani J, Hyer SL, Rodin DA, Shehata H. Diabet Med. 2009 Aug;26(8):798-802. doi: 10.1111/j.1464-5491.2009.02780.x. PMID: 19709150 |
27. | Uterus didelphys in mosaic trisomy 8 patient: Management and fertility issues. Shehata H, Gharaibeh A, Bramham K, Lamb G, Makanjuola D. Eur J Obstet Gynecol Reprod Biol. 2008 Nov;141(1):91-2. doi: 10.1016/j.ejogrb.2008.07.011. Epub 2008 Oct 8. PMID: 18845375 No abstract available. |
28. | Diabetes in pregnancy: a review of current evidence. Kapoor N, Sankaran S, Hyer S, Shehata H. Curr Opin Obstet Gynecol. 2007 Dec;19(6):586-90. doi: 10.1097/GCO.0b013e3282f20aad. PMID: 18007138 Review. |
29. | Menorrhagia and bleeding disorders. El-Hemaidi I, Gharaibeh A, Shehata H. Curr Opin Obstet Gynecol. 2007 Dec;19(6):513-20. doi: 10.1097/GCO.0b013e3282f1ddbe. PMID: 18007127 Review. |
30. | Asgari E, Bramham K, Shehata H, Makanjuola D. Nephrol Dial Transplant. 2007 Dec;22(12):3671. doi: 10.1093/ndt/gfm280. Epub 2007 Sep 11. PMID: 17848397 No abstract available. |
31. | Thum MY, Abdalla HI, Bhaskaran S, Harden EL, Ford B, Sumar N, Shehata H, Bansal A. Am J Reprod Immunol. 2007 Mar;57(3):210-7. doi: 10.1111/j.1600-0897.2006.00465.x. PMID: 17295900 |
32. | Thum MY, Abdalla HI, Bhaskaran S, Harden EL, Ford B, Sumar N, Shehata H, Bansal AS. Am J Reprod Immunol. 2006 Jan;55(1):76-80. doi: 10.1111/j.1600-0897.2005.00328.x. PMID: 16364015 |
33. | Thum MY, Bhaskaran S, Bansal AS, Shehata H, Ford B, Sumar N, Abdalla HI. Hum Reprod. 2005 May;20(5):1272-6. doi: 10.1093/humrep/deh774. Epub 2005 Apr 13. PMID: 15829490 |
34. | Thum MY, Bhaskaran S, Abdalla HI, Ford B, Sumar N, Shehata H, Bansal AS. Hum Reprod. 2004 Oct;19(10):2395-400. doi: 10.1093/humrep/deh378. Epub 2004 Aug 19. PMID: 15319390 |
35. | Use of cyclosporin in pregnancy. Jayaprakash A, Gould S, Lim AG, Shehata HA. Gut. 2004 Sep;53(9):1386-7. doi: 10.1136/gut.2003.036103. PMID: 15306605 Free PMC article. No abstract available. |
36. | Obstetric complications of twin pregnancies. Rao A, Sairam S, Shehata H. Best Pract Res Clin Obstet Gynaecol. 2004 Aug;18(4):557-76. doi: 10.1016/j.bpobgyn.2004.04.007. PMID: 15279817 Review. |
37. | Respiratory disease in pregnancy. Bhide A, Shehata HA. Curr Obstet Gynaecol. 2004 Jun;14(3):175-182. doi: 10.1016/j.curobgyn.2004.02.002. Epub 2004 May 6. PMID: 32288339 Free PMC article. |
38. | Neurological disorders in pregnancy. Shehata HA, Okosun H. Curr Opin Obstet Gynecol. 2004 Apr;16(2):117-22. doi: 10.1097/00001703-200404000-00004. PMID: 15017339 Review. |
39. | Drugs in pregnancy. Drugs to avoid. Shehata HA, Nelson-Piercy C. Best Pract Res Clin Obstet Gynaecol. 2001 Dec;15(6):971-86. doi: 10.1053/beog.2001.0241. PMID: 11800536 Review. |
40. | Internal jugular vein thrombosis after assisted conception therapy. Arya R, Shehata HA, Patel RK, Sahu S, Rajasingam D, Harrington KF, Nelson-Piercy C, Parsons JH. Br J Haematol. 2001 Oct;115(1):153-5. doi: 10.1046/j.1365-2141.2001.03081.x. PMID: 11722427 |
41. | Management of pregnancy in antiphospholipid syndrome. Shehata HA, Nelson-Piercy C, Khamashta MA. Rheum Dis Clin North Am. 2001 Aug;27(3):643-59. doi: 10.1016/s0889-857x(05)70226-x. PMID: 11534266 Review. |
42. | Fasciitis: a rare complication of Burch colposuspension. Georgiou M, Shehata HA, Chaliha C, Byrne PD, McWhinney NA, Gough PM. BJOG. 2001 Feb;108(2):227-9. doi: 10.1111/j.1471-0528.2001.00027.x. PMID: 11236127 No abstract available. |
43. | Oyelese KO, Shehata H, Hussain S, Manyonda I. J Obstet Gynaecol. 1999 May;19(3):276-9. doi: 10.1080/01443619965066. PMID: 15512295 |
44. | Red cell distribution width (RDW) changes in pregnancy. Shehata HA, Ali MM, Evans-Jones JC, Upton GJ, Manyonda IT. Int J Gynaecol Obstet. 1998 Jul;62(1):43-6. doi: 10.1016/s0020-7292(98)00069-1. PMID: 9722124 |
In the realm of global health, Professor Shehata leads initiatives aimed at influencing health policy and improving sexual, reproductive, and post-reproductive healthcare worldwide. He advocates for women’s health rights, working diligently to increase healthcare access and amplify the voices of underserved women, particularly in relation to FGM, obesity, and ethnic health disparities. He developed the RCOG FGM Advocacy & Training Toolkit to combat the medicalisation of FGM and support global education efforts. Professor Shehata is committed to assisting RCOG’s global members by adapting guidelines to local contexts and ensuring the relevance of the MRCOG qualification in diverse healthcare settings. He actively drives the RCOG’s philanthropic role by expanding strategic global health projects to maximize impact.
Professor Shehata has served as an MRCOG examiner for the MRCOG Part 1, 2, and 3 exams on numerous occasions, including the Part 3 exam conducted on both virtual platforms and in person. He is closely associated with the Medical Trainees Initiative (MTI) scheme and Global Health trainees since 2022, actively participating in MTI activities within the RCOG and utilising peer-to-peer platforms to maintain effective communication. As the co-director of the Saving Mothers and Babies Lives Training Course in Jordan since 2022, he has led initiatives to enhance skills in managing obstetric emergencies, successfully training approximately 150 healthcare professionals to date. Additionally, he serves as the Director of the Anti-Medicalisation FGM Ethical and Advocacy Toolkit since 2023, where he developed a specialised training program to equip healthcare professionals with the knowledge and skills to recognise the harms of FGM/C and advocate for its eradication within their communities.
Professor Shehata has held various external roles, including serving as a CEMACH Maternal Death Assessor from 2009 to 2010, and as a member of the NICE IOL Guidelines Development Group during two periods (2007-2008, 2013-2014). He was also a National Structure Framework Diabetes Assessor from 2003 to 2004 and served on the Executive Committee of Physicians for Human Rights (PHR) from 1996 to 2001. Additionally, he participated in a local BMA advisory committee from 2018 to 2022. Currently, he is a member of the Maternal Reducing Inequalities Care Bundle (MRCIB) Steering Group, providing strategic oversight to ensure alignment with the London Regional Maternity Team’s vision for achieving equity in maternity outcomes. He is also a member of the FIGO Women’s Health & Technology Committee, advocating for equitable innovation and digitalisation in women’s health.
In leadership positions, Professor Shehata served as Clinical Director from 2009 to 2015 and Division Director from 2015 to 2018. During his tenure, he facilitated the appointment of ten new consultants, enabling the trust to meet the RCOG recommendations for labour ward consultant cover. He successfully led the initiative to achieve Baby-Friendly Initiative (BFI) level 1 status, the highest rating in the sector, while also reducing the caesarean section rate from 35% to 27% while maintaining excellent perinatal outcomes. He achieved CNST level 3 in 2014 through collaborative work across specialties, including the revision of complex obstetric care guidelines. In his current role as Clinical Director of the Maternal Medicine Network for South West London and Surrey Heartlands since 2021, he is responsible for the day-to-day operation of services, job planning, appraisals, strategic planning, and governance structure development, as well as for integrating regional maternal medicine services and managing complex cases at the Co-Hubs to ensure timely and appropriate care.
Throughout his career, Professor Shehata has developed innovative models of care that have gained national and international recognition. He founded the South London and Surrey Recurrent Miscarriage Clinic in 2002, which has achieved national acclaim for its pioneering research and management approaches. In 2001, he established the Obstetric Medicine Clinic, where he has mentored trainees and implemented evidence-based protocols. He has also developed obstetric specialist clinics that enhance care quality through expert-led services and co-founded the regional Renal/Obstetric service, which provides specialised preconception and antenatal care. Additionally, he co-founded and led the internationally recognised “Saving Mothers and Babies Lives” and ALSO courses, significantly improving maternal outcomes on a global scale.
Professor Shehata has extensive clinical experience as an Obstetrician and Gynaecologist and currently serves as a Lead Maternal Medicine Consultant since 2001. He possesses specialist expertise as a senior clinician, trainer, and academic in areas such as recurrent miscarriage and maternal medicine, including obesity and diabetes services. He is recognised as an expert in pre-conception counselling for high-risk obstetric patients, managing a diverse range of conditions—including diabetes, antiphospholipid syndrome (APS), thyroid disorders, neurological issues, cardiovascular diseases, respiratory conditions, and renal complications—through individualised assessments and treatment plans. The maternal medicine centre he leads is accredited for RCOG training and is recognised as a Co-Hub for the South West London and Surrey Heartlands Maternal Medicine Network.
Professor Shehata served as the MENA Region International Fellows Representative on the RCOG Council from 2016 to 2022, playing a pivotal role in enhancing communication between the MENA Region International Representatives, Liaison Groups, and the College. During his tenure as the RCOG MENA Region Webinars Lead from 2020 to 2021, he successfully organised a series of webinars that were conducted almost weekly, achieving impressive attendance figures ranging from 1,200 to 3,000 participants per session.
From 2013 to 2016, Professor Shehata acted as the RCOG Gulf Ambassador, during which he significantly strengthened partnerships, fostered collaboration, and promoted training and education initiatives across Gulf countries. His efforts contributed to a marked increase in the RCOG’s presence and influence within the region. Furthermore, he was an active participant in the RCOG Workforce Task Group from 2008 to 2009, where he engaged in strategic initiatives focused on workforce sustainability and played a key role in shaping policies aimed at recruitment, retention, and well-being to effectively address future healthcare demands.